Weight Loss Drugs Won’t Eat Into Food Industry Profits, Nestlé CEO Says

Mark Schneider News

Weight Loss Drugs Won’t Eat Into Food Industry Profits, Nestlé CEO Says
NestleGlp-1Ozempic
  • 📰 Forbes
  • ⏱ Reading Time:
  • 12 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 53%

Robert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.

What If Trump Jurors Can’t Reach A Verdict? Here’s What The Hush Money Case Judge Can Do To End A Hung Jury.Nestlé is tapping into the lucrative weight loss drug market by catering to customers’ “shifting” nutritional needs, CEO Mark Schneider CNBC on Thursday, an optimistic pivot from one of the industry’s biggest players in the face of dire early predictions suggesting wildly popular drugs like Ozempic , Mounjaro and Wegovy would take a bite out of the food industry.

Schneider said the different needs of people using weight loss drugs open up a big market opportunity for companies like Nestlé, which he said has big plans to respond to what has rapidly become a “major consumer trend.”

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Forbes /  🏆 394. in US

Nestle Glp-1 Ozempic Wegovy Weight Loss Drugs Obesity Drugs Food Industry Buy Less Food Mounjaro

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

7 Best Free-Weight Workouts To Maintain Weight Loss7 Best Free-Weight Workouts To Maintain Weight LossYour ultimate source for expert nutrition tips and health advice, covering wellness, healthy recipes, cooking hacks, food news, style trends and shopping.
Read more »

'Turbocharged' New Weight-Loss Drug Has Patients Losing 24% of Body Weight'Turbocharged' New Weight-Loss Drug Has Patients Losing 24% of Body WeightDigital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Read more »

Weight Loss Drugs Won’t Eat Into Food Industry Profits, Nestlé CEO SaysWeight Loss Drugs Won’t Eat Into Food Industry Profits, Nestlé CEO SaysRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »

Nutritional needs are 'shifting' amid rise of weight loss drugs, says Nestle CEONutritional needs are 'shifting' amid rise of weight loss drugs, says Nestle CEOConsumers' nutritional needs are 'shifting' amid the rise of weight loss drugs, which is an opportunity for food companies, Nestle CEO Mark Schneider said.
Read more »

Supplies of Wegovy and Other Weight Loss Drugs Can Now Be Tracked by PatientsSupplies of Wegovy and Other Weight Loss Drugs Can Now Be Tracked by PatientsHealthcare company Ro just launched a GLP-1 supply tracker. Eli Lilly is working on one, too
Read more »

Understanding diet, nutritional needs while on weight loss drugsUnderstanding diet, nutritional needs while on weight loss drugsMaya Feller explains balanced plates and what drugs like Ozempic do to appetite.
Read more »



Render Time: 2025-04-01 13:13:10